Tc-99m MAG3

Andrew Murphy and Dr Jeremy Jones et al.

Tc-99m MAG3 (mercaptoacetyltriglycine) is one of the technetium radiopharmaceuticals used in renal imaging.


  • photon energy: 140 KeV
  • physical half life: 6 hours
  • biological half life: 4 hours
  • technetium oxidation state: +5
  • normal distribution: kidneys (100%)
  • pharmacokinetics:
    • uptake by tubular secretion (97%)
    • first pass filtration 60%
  • excretion: renal via both glomerular filtration and tubular excretion; hence, in pediatric patients and patients with poor renal function this test is considered superior to DTPA scan
  • target organ: bladder
  • miscellaneous facts
    • good quality images with renal insufficiency
    • by giving captopril, MAG3 plasma clearance decreases in hypertensive patients with renal artery stenosis but increases in patients without renal artery stenosis
    • cannot measure GFR as it is cleared almost entirely by tubular secretion

Uses, doses and timings

  • renal study
    • adult dose: 296 MBq (8 mCi) IV
    • pediatric dose: 3.7 MBq/kg (0.10 mCi/kg) (minimum: 14.8 MBq (0.4 mCi)) 5
    • 60 sec flow study; then every 5 min for 25 min
Imaging technology

Article information

rID: 15558
System: Urogenital
Synonyms or Alternate Spellings:
  • Technetium-99m mercaptoacetyltriglycine (MAG3)
  • Technicium-99m MAG3
  • Technetium-99m mercaptoacetyltriglycine
  • MAG3

Support Radiopaedia and see fewer ads

Cases and figures

  • Right PUJ obstruc...
    Case 1: pelviureteric junction (PUJ) obstruction
    Drag here to reorder.
  • Case 2: normal
    Drag here to reorder.
  • Updating… Please wait.

     Unable to process the form. Check for errors and try again.

     Thank you for updating your details.